Steven Sell compensation by year
agilon health Summary Compensation Table · all 6 fiscal years held| Component | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Salary | $432,692 | $750,000 | $750,000 | $750,000 | $750,000 | $431,507 |
| Bonus | — | $0 | $0 | $0 | $0 | $0 |
| Stock awards | — | $0 | $2,250,017 | $3,375,043 | $3,375,007 | $4,050,004 |
| Option awards | $5,277,000 | $0 | $4,500,031 | $1,125,008 | $1,125,002 | $2,250,001 |
| Non-equity incentive | $328,893 | $506,250 | $523,125 | $0 | $161,438 | $0 |
| Pension and deferred compensation | — | $0 | $0 | $0 | $0 | $0 |
| All other | — | $0 | $16,000 | $16,985 | $4,596 | $546,875 |
| Total | $6,038,585 | $1,256,250 | $8,039,173 | $5,267,036 | $5,416,043 | $7,278,387 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: agilon health, inc. DEF 14A filed April 22, 2026, accession 0001628280-26-026544, and prior-year filings. Open the filing on EDGAR.
How this page was built: the agilon health, inc. filed document, accession 0001628280-26-026544. Every figure is read from that document and cited to the page and table it appears in. Filed April 22, 2026.
Equity holdings
unvested awards at FY2024 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| Option | 415,130 | — | $4.46 |
| Option | 500,000 | — | $10.12 |
| Option | 400,000 | — | $4.50 |
| Option | 80,244 | — | $23.07 |
| Option | 51,261 | — | $28.46 |
Per the Outstanding Equity Awards at Fiscal Year-End table in agilon health, inc.'s FY2024 proxy; value at the fiscal year-end close, as the company printed it.
Change-in-control & termination
estimated payments agilon health discloses, by trigger · FY2025| Trigger | Cash severance | Accelerated equity | Benefits continuation | Total as disclosed |
|---|---|---|---|---|
| Voluntary resignation | $1,687,500 | — | $42,145 | $1,729,645 |
Per the Potential Payments Upon Termination or Change in Control table in agilon health, inc.'s FY2025 proxy. Estimates as the company printed them; a dash means it printed no figure.
agilon health’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| Steven Sell · this page | Former Chief Executive Officer and President | $7,278,387 |
| Jeffrey Schwaneke | Chief Financial Officer and Interim Co-Principal Executive Officer | $5,610,878 |
| Benjamin Shaker | Chief Markets Officer and Interim Co-Principal Executive Officer | $5,357,548 |
| Denise Zamore | Chief Legal Officer and Corporate Secretary | $3,123,418 |
| Girish Venkatachaliah | Chief Technology Officer | $2,056,086 |
Board service
agilon health board · FY2023–FY2025How this board is paid
Company policy: agilon health pays directors a $70,000 cash retainer and $185,000 in equity. As stated in agilon health's FY2025 proxy.
Steven Sell's compensation dossier, agilon health
You have read Steven Sell's totals and holdings. The dossier adds each equity grant agilon health disclosed for Steven Sell and agilon health's own disclosed peer group, where the company discloses them, with every row in a PDF and a CSV cited to its filing.
See an example →The full agilon health compensation record
free company briefThis page is one person within agilon health's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the agilon health proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order agilon health's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are agilon health's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.
Order AGL
Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.